Individualized controlled ovarian stimulation in expected poor-responders: an update

Abstract Controlled ovarian stimulation with subsequent multi-follicular development continues to be a keystone in ART. Evidence supports an individualized approach to ovarian stimulation, usually involving combinations of ovarian reserve tests, body mass index and age to tailor the exogenous gonado...

Full description

Bibliographic Details
Main Authors: Thor Haahr, Sandro C. Esteves, Peter Humaidan
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Reproductive Biology and Endocrinology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12958-018-0342-1
id doaj-36b5ff8a0fbc4377b8c4dbbdba2ba33d
record_format Article
spelling doaj-36b5ff8a0fbc4377b8c4dbbdba2ba33d2020-11-25T03:26:22ZengBMCReproductive Biology and Endocrinology1477-78272018-03-011611910.1186/s12958-018-0342-1Individualized controlled ovarian stimulation in expected poor-responders: an updateThor Haahr0Sandro C. Esteves1Peter Humaidan2Department of Clinical Medicine, Aarhus University, Denmark and the Fertility Clinic Skive, Skive Regional HospitalDepartment of Clinical Medicine, Aarhus University, Denmark and the Fertility Clinic Skive, Skive Regional HospitalDepartment of Clinical Medicine, Aarhus University, Denmark and the Fertility Clinic Skive, Skive Regional HospitalAbstract Controlled ovarian stimulation with subsequent multi-follicular development continues to be a keystone in ART. Evidence supports an individualized approach to ovarian stimulation, usually involving combinations of ovarian reserve tests, body mass index and age to tailor the exogenous gonadotropin dose, and potentially adjuvant treatment aiming for high safety and a shortening of time to live birth. While stimulation and trigger concepts have been developed successfully in normo- and hyperresponder patients, the poor responder patient remains difficult to manage. However, recent advances in definition and classification of the expected poor ovarian responder patient might enable a more accurate and clinically useful interpretation of new treatment concepts in a more homogenous study population. In the present review, we discuss the classification of the expected poor ovarian responder patient as well as clinically useful measurements of efficacy for controlled ovarian stimulation, and finally, we discuss the evidence for clinical management of patients with expected poor ovarian response, including adjuvant treatments such as growth hormone, androgens, and LH activity. In conclusion, the best available evidence supports that the treatment of the expected poor ovarian response patient should be individualized in all steps of ART, including the choice of GnRH analogue, the gonadotropin type and dose, ovulation trigger, and the possible use of adjuvant therapies.http://link.springer.com/article/10.1186/s12958-018-0342-1Poor ovarian responseBologna criteriaPoseidon classificationART calculatorControlled ovarian stimulationAdjuvant therapy
collection DOAJ
language English
format Article
sources DOAJ
author Thor Haahr
Sandro C. Esteves
Peter Humaidan
spellingShingle Thor Haahr
Sandro C. Esteves
Peter Humaidan
Individualized controlled ovarian stimulation in expected poor-responders: an update
Reproductive Biology and Endocrinology
Poor ovarian response
Bologna criteria
Poseidon classification
ART calculator
Controlled ovarian stimulation
Adjuvant therapy
author_facet Thor Haahr
Sandro C. Esteves
Peter Humaidan
author_sort Thor Haahr
title Individualized controlled ovarian stimulation in expected poor-responders: an update
title_short Individualized controlled ovarian stimulation in expected poor-responders: an update
title_full Individualized controlled ovarian stimulation in expected poor-responders: an update
title_fullStr Individualized controlled ovarian stimulation in expected poor-responders: an update
title_full_unstemmed Individualized controlled ovarian stimulation in expected poor-responders: an update
title_sort individualized controlled ovarian stimulation in expected poor-responders: an update
publisher BMC
series Reproductive Biology and Endocrinology
issn 1477-7827
publishDate 2018-03-01
description Abstract Controlled ovarian stimulation with subsequent multi-follicular development continues to be a keystone in ART. Evidence supports an individualized approach to ovarian stimulation, usually involving combinations of ovarian reserve tests, body mass index and age to tailor the exogenous gonadotropin dose, and potentially adjuvant treatment aiming for high safety and a shortening of time to live birth. While stimulation and trigger concepts have been developed successfully in normo- and hyperresponder patients, the poor responder patient remains difficult to manage. However, recent advances in definition and classification of the expected poor ovarian responder patient might enable a more accurate and clinically useful interpretation of new treatment concepts in a more homogenous study population. In the present review, we discuss the classification of the expected poor ovarian responder patient as well as clinically useful measurements of efficacy for controlled ovarian stimulation, and finally, we discuss the evidence for clinical management of patients with expected poor ovarian response, including adjuvant treatments such as growth hormone, androgens, and LH activity. In conclusion, the best available evidence supports that the treatment of the expected poor ovarian response patient should be individualized in all steps of ART, including the choice of GnRH analogue, the gonadotropin type and dose, ovulation trigger, and the possible use of adjuvant therapies.
topic Poor ovarian response
Bologna criteria
Poseidon classification
ART calculator
Controlled ovarian stimulation
Adjuvant therapy
url http://link.springer.com/article/10.1186/s12958-018-0342-1
work_keys_str_mv AT thorhaahr individualizedcontrolledovarianstimulationinexpectedpoorrespondersanupdate
AT sandrocesteves individualizedcontrolledovarianstimulationinexpectedpoorrespondersanupdate
AT peterhumaidan individualizedcontrolledovarianstimulationinexpectedpoorrespondersanupdate
_version_ 1724593223625605120